뉴로원 메디컬 테크놀로지스 (NMTC) 주가

뉴로원 메디컬 테크놀로지스(NMTC)는 NASDAQ에 상장된 Healthcare · Medical Devices 기업입니다. 현재가 $1.94 (+6.01%), 시가총액 $0.04B, 52주 범위 $0.56 ~ $5.11.

NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company has a collaboration with the Department of Neurology's Division of Epilepsy at the University of Minnesota Medical School to advance a study evaluating epil

핵심 지표

• 현재가: $1.94 (+6.01%)
• 시가총액: $0.04B
• 52주 최저~최고: $0.56 ~ $5.11
• 섹터: Healthcare
• 산업: Medical Devices
• 거래소: NASDAQ

뉴로원 메디컬 테크놀로지스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.

뉴로원 메디컬 테크놀로지스 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 5

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 6.75
• 순이익률: -0.52%
• 영업이익률: -0.88%

자주 묻는 질문